|
|
|
|
| LEADER |
03566cam a22007097a 4500 |
| 001 |
BIBLO-50776 |
| 003 |
AR-BaUEN |
| 005 |
20220517121021.0 |
| 008 |
190627s2014 xxka|d|f |||| 00| 0|eng|d |
| 020 |
|
|
|a 9781118912492
|
| 040 |
|
|
|a AR-BaUEN
|b spa
|c AR-BaUEN
|
| 044 |
|
|
|a xxk
|
| 080 |
|
|
|a 575
|
| 100 |
1 |
|
|a Zneimer, Susan Mahler
|
| 245 |
1 |
0 |
|a Cytogenetic abnormalities :
|b chromosomal, FISH and microarray-based clinical reporting
|
| 260 |
|
|
|a West Sussex :
|b John Wiley & Sons,
|c 2014
|
| 300 |
|
|
|a xiii, 647 p. :
|b il., gráfs.
|
| 504 |
|
|
|a Bibliografía al final de cada capítulo.
|
| 504 |
|
|
|a Índice analítico de materias.
|
| 505 |
0 |
0 |
|g 1
|t Components of a standard cytogenetics report, normal results and culture failures
|
| 505 |
0 |
0 |
|g 2
|t Mosaicism
|
| 505 |
0 |
0 |
|g 3
|t Autosomal trisomies-prenatal and livebirths
|
| 505 |
0 |
0 |
|g 4
|t Translocations
|
| 505 |
0 |
0 |
|g 5
|t Inversions and rercombinant chromosomes
|
| 505 |
0 |
0 |
|g 6
|t Visible deletions, duplications and insertions
|
| 505 |
0 |
0 |
|g 7
|t Unidentifiable marker chromosomes, derivative chromosomes, chromosomes with additional material and rings
|
| 505 |
0 |
0 |
|g 8
|t Isochromosomes, dicentric chromosomes and pseudodicentric chromosomes
|
| 505 |
0 |
0 |
|g 9
|t Composite karyotypes and other complex rearrangements
|
| 505 |
0 |
0 |
|g 10
|t Sex chromosome abnormalities
|
| 505 |
0 |
0 |
|g 11
|t Fetal demises/spontaneous abortions
|
| 505 |
0 |
0 |
|g 12
|t Uniparrental disomy
|
| 505 |
0 |
0 |
|g 13
|t Metaphase analysis
|
| 505 |
0 |
0 |
|g 14
|t Interphase analysis
|
| 505 |
0 |
0 |
|g 15
|t Integrated chromosome and FISH analyses
|
| 505 |
0 |
0 |
|g 16
|t Bacterial artificial chromosome, oligoarray and single nucleotide polymorphism array methodologies for analysis
|
| 505 |
0 |
0 |
|g 17
|t Microarray abnormal results
|
| 505 |
0 |
0 |
|g 18
|t Pathogenic chromosomal microarray copy number changes by chromosome order
|
| 505 |
0 |
0 |
|g 19
|t Integrated reports with cytogenetics, FISH and microarrays
|
| 505 |
0 |
0 |
|g 20
|t Introduction
|
| 505 |
0 |
0 |
|g 21
|t Results with constitutional or other non-neoplastic abnormalities
|
| 505 |
0 |
0 |
|g 22
|t Cytogenetic abnormalities in myeloid disorders
|
| 505 |
0 |
0 |
|g 23
|t Cytogenetic abnormalities in lymphoid disorders
|
| 505 |
0 |
0 |
|g 24
|t Common biphenotypic abnormalities and secondary changes
|
| 505 |
0 |
0 |
|g 25
|t Reporting complex abnormalities and multiple cell lines
|
| 505 |
0 |
0 |
|g 26
|t Breakage disorders
|
| 505 |
0 |
0 |
|g 27
|t Cytogenetic abnormalities in solid tumors
|
| 505 |
0 |
0 |
|g 28
|t Introduction to FISH analysis for hematological disorders and solid tumors
|
| 505 |
0 |
0 |
|g 29
|t Recurrent FISH abnormalities in myeloid disorders
|
| 505 |
0 |
0 |
|g 30
|t Recurrent FISH abnormalities in lymphoid disorders
|
| 505 |
0 |
0 |
|g 31
|t Integrated reports with cytogenetics and FISH in hematological malignancies
|
| 505 |
0 |
0 |
|g 32
|t Recurrent FISH abnormalities in solid tumors using paraffin-embedded tissue
|
| 505 |
0 |
0 |
|g 33
|t Breast cancer - HER2 FISH analysis
|
| 505 |
0 |
0 |
|g 34
|t Bladder cancer FISH analysis
|
| 505 |
0 |
0 |
|g 35
|t Chromosomal microarray analysis for hematological disorders
|
| 505 |
0 |
0 |
|g 36
|t Chromosomal microarrays for tumors
|
| 505 |
0 |
0 |
|g 37
|t Integrated reports with chromosomes, FISH and microarrays
|
| 505 |
0 |
0 |
|t Appendix 1: Example assay-specific reagent (ASR) FISH validation plan for constitutional disorders and hematological malignancies on fresh tissue
|
| 650 |
1 |
7 |
|2 spines
|a CITOGENETICA
|
| 650 |
1 |
7 |
|2 spines
|a CROMOSOMAS
|
| 653 |
1 |
0 |
|a HIBRIDACION FLUORESCENTE IN SITU (FISH)
|
| 962 |
|
|
|a info:eu-repo/semantics/book
|a info:ar-repo/semantics/libro
|b info:eu-repo/semantics/publishedVersion
|
| 999 |
|
|
|c 38954
|